Channelling the Force to Reprogram the Matrix: Mechanosensitive Ion Channels in Cardiac Fibroblasts

par Stewart, Leander, Turner, Neil A.
Publié dans Cells (2021)

Function and fate of myofibroblasts after myocardial infarction

par Turner, Neil A, Porter, Karen E
Publié 2013

Cardiac Fibroblast p38 MAPK: A Critical Regulator of Myocardial Remodeling

par Turner, Neil A., Blythe, Nicola M.
Publié dans J Cardiovasc Dev Dis (2019)

Modulatory effect of interleukin-1α on expression of structural matrix proteins, MMPs and TIMPs in human cardiac myofibroblasts: Role of p38 MAP kinase

par Turner, Neil A., Warburton, Philip, O'Regan, David J., Ball, Stephen G., Porter, Karen E.
Publié 2010

A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice

par Frentzou, Georgia A., Drinkhill, Mark J., Turner, Neil A., Ball, Stephen G., Ainscough, Justin F. X.
Publié dans Dis Model Mech (2015)

p38 MAPK alpha mediates cytokine-induced IL-6 and MMP-3 expression in human cardiac fibroblasts

par Sinfield, John K., Das, Anupam, O’Regan, David J., Ball, Stephen G., Porter, Karen E., Turner, Neil A.
Publié 2013

Piezo1 Mechanosensitive Ion Channel Mediates Stretch-Induced Nppb Expression in Adult Rat Cardiac Fibroblasts

par Ploeg, Meike C., Munts, Chantal, Prinzen, Frits W., Turner, Neil A., van Bilsen, Marc, van Nieuwenhoven, Frans A.
Publié dans Cells (2021)

Mapping the methylation status of the miR-145 promoter in saphenous vein smooth muscle cells from individuals with type 2 diabetes

par Riches, Kirsten, Huntriss, John, Keeble, Claire, Wood, Ian C, O’Regan, David J, Turner, Neil A, Porter, Karen E
Publié dans Diab Vasc Dis Res (2016)

Role of MicroRNA-145 in DNA Damage Signalling and Senescence in Vascular Smooth Muscle Cells of Type 2 Diabetic Patients

par Hemmings, Karen E., Riches-Suman, Kirsten, Bailey, Marc A., O’Regan, David J., Turner, Neil A., Porter, Karen E.
Publié dans Cells (2021)

Chronic hypoxia inhibits MMP-2 activation and cellular invasion in human cardiac myofibroblasts

par Riches, Kirsten, Morley, Michael E., Turner, Neil A., O'Regan, David J., Ball, Stephen G., Peers, Chris, Porter, Karen E.
Publié 2009

Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function

par Riches, Kirsten, Alshanwani, Aliah R., Warburton, Philip, O’Regan, David J., Ball, Stephen G., Wood, Ian C., Turner, Neil A., Porter, Karen E.
Publié 2014

Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism

par Bageghni, Sumia A., Hemmings, Karen E., Zava, Ngonidzashe, Denton, Christopher P., Porter, Karen E., Ainscough, Justin F. X., Drinkhill, Mark J., Turner, Neil A.
Publié dans FASEB J (2018)

Exposure to inflammatory cytokines selectively limits GM-CSF production by induced T regulatory cells

par Reynolds, Ben C, Turner, Darryl G, McPherson, Rhoanne C, Prendergast, Catriona T, Phelps, Richard G, Turner, Neil A, O'Connor, Richard A, Anderton, Stephen M
Publié dans Eur J Immunol (2014)

Aberrant Phenotype in Human Endothelial Cells of Diabetic Origin: Implications for Saphenous Vein Graft Failure?

par Roberts, Anna C., Gohil, Jai, Hudson, Laura, Connolly, Kyle, Warburton, Philip, Suman, Rakesh, O'Toole, Peter, O'Regan, David J., Turner, Neil A., Riches, Kirsten, Porter, Karen E.
Publié dans J Diabetes Res (2015)

Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4

par Maqbool, Azhar, Spary, Emma J, Manfield, Iain W, Ruhmann, Michaela, Zuliani-Alvarez, Lorena, Gamboa-Esteves, Filomena O, Porter, Karen E, Drinkhill, Mark J, Midwood, Kim S, Turner, Neil A
Publié dans World J Cardiol (2016)

Apolipoprotein(a) acts as a chemorepellent to human vascular smooth muscle cells via integrin α(V)β(3) and RhoA/ROCK-mediated mechanisms()

par Riches, Kirsten, Franklin, Larissa, Maqbool, Azhar, Peckham, Michelle, Adams, Matthew, Bond, Jacquelyn, Warburton, Philip, Feric, Nicole T., Koschinsky, Marlys L., O’Regan, David J., Ball, Stephen G., Turner, Neil A., Porter, Karen E.
Publié 2013

11β-HSD1 suppresses cardiac fibroblast CXCL2, CXCL5 and neutrophil recruitment to the heart post MI

par Mylonas, Katie J, Turner, Neil A, Bageghni, Sumia A, Kenyon, Christopher J, White, Christopher I, McGregor, Kieran, Kimmitt, Robert A, Sulston, Richard, Kelly, Valerie, Walker, Brian R, Porter, Karen E, Chapman, Karen E, Gray, Gillian A
Publié dans J Endocrinol (2017)

Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction

par Bageghni, Sumia A., Hemmings, Karen E., Yuldasheva, Nadira Y., Maqbool, Azhar, Gamboa-Esteves, Filomena O., Humphreys, Neil E., Jackson, Maj Simonsen, Denton, Christopher P., Francis, Sheila, Porter, Karen E., Ainscough, Justin F.X., Pinteaux, Emmanuel, Drinkhill, Mark J., Turner, Neil A.
Publié dans JCI Insight (2019)

Mechanically activated Piezo1 channels of cardiac fibroblasts stimulate p38 mitogen-activated protein kinase activity and interleukin-6 secretion

par Blythe, Nicola M., Muraki, Katsuhiko, Ludlow, Melanie J., Stylianidis, Vasili, Gilbert, Hamish T. J., Evans, Elizabeth L., Cuthbertson, Kevin, Foster, Richard, Swift, Joe, Li, Jing, Drinkhill, Mark J., van Nieuwenhoven, Frans A., Porter, Karen E., Beech, David J., Turner, Neil A.
Publié dans J Biol Chem (2019)